Glenmark Pharmaceuticals informs about board meeting

27 Jul 2017 Evaluate

Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, Glenmark Pharmaceuticals has informed that Board has today at its meeting approved the Unaudited Financial Results for the First Quarter ended June 30, 2017.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1079.55 8.25 (0.77%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.